Kyowa Kirin North America News and Activities

Kyowa Kirin North America is owned by Kirin.

Kirin is one of the...

• Forbes Global 2000 (#1280);
• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Kirin is a company listed under the stock ticker 2503 (JP).

Kirin has a direct presence in 3 countries.

Kirin has 6 subsidiaries including Coca-Cola Beverages Northeast, Kyowa Chemical Industry and Kyowa Hakko Kirin.

They are in:

• Beverages29%
• Pharmaceuticals29%
• Other43%

View the org chart displaying its 17 main executives

Most searched biographies at Kyowa Kirin North America

• Steve Schaefer, President
• Eslie Dennis, Senior Vice President and Chief Medical Officer
• Gunnar Kaufmann, Chief Scientific Officer and Head of Bio-Innovati...

Popular executive movements at Kyowa Kirin North America

• Hidekuni Kaito, who was Senior Vice President and Head, Global Precipitation Measurement, is promoted to Vice Head of Global Development Organization  (posted on May 5 2026).

Create your alert
to follow the executive moves at Kyowa Kirin North America.

Kirin has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by Kyowa Kirin North America

Social media about Kyowa Kirin North America

• Kyowa Kirin North America on Wikipedia, Google News & Yahoo Finance
• Kyowa Kirin North America on LinkedIn, X (Twitter) & YouTube